InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Wellington Biomedical Innovation Master Investors (Cayman) II L.P.. Officer active across 6 companies, notably RayzeBio, Inc.. Aggregated, 6 reports have been published. Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. is a declarant with 6 filings in total. In the 6 sampled recent filings, the period runs from 2023-09-19 to 2026-05-01, with sum_buy_eur at 0 and sum_sell_eur at 0. It is associated with Avalyn Pharma Inc. as a 10% Owner, and with Metsera, Inc., Upstream Bio, Inc., MBX Biosciences, Inc., CARGO Therapeutics, Inc., and RayzeBio, Inc.